Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-04-17 @ 12:27 AM
Study NCT ID:
NCT00763360
Status:
COMPLETED
Last Update Posted:
2012-01-24
First Post:
2008-09-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AUS-S-07-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None